Free BCACP Practice Questions by Eric Christianson | Nov 11, 2022 | 0 comments 1. T-Score and Treatment LS is a 71-year-old postmenopausal female with a T-score of -3.5. What would be an appropriate next step in the management of this patient? Initiate alendronate Initiate calcitonin Do FRAX scoring to assess the 10-year risk of fracture prior to determining if therapy is appropriate (if the 10-year risk of hip fracture is ≥ 1%, therapy should be initiated) Perform a second T-score in 1 year and if it is worse than -3.5, then initiate therapy None 2. Dementia and Incontinence Medications As the ambulatory care pharmacy specialist on the healthcare team, a nurse practitioner requests your help in dealing with a patient who has urinary incontinence and dementia. She would like to utilize a urinary anticholinergic agent to help with the patient's symptoms. Which agent would be least likely to exacerbate dementia symptoms? Trospium Oxybutynin Tolterodine Fesoterodine None 3. Ambulatory Care Services - Pro Forma In developing a business model for ambulatory care services, your manager asks you to create a pro forma. Which of the following best describes this process as it relates to your new services? A detailed description of benefits and risks to the patient A detailed description of benefits and risks to the business A financial statement showing expected income and costs of new services to be provided A standard consent form developed for patients to sign to protect the business/institution from lawsuits None 4. DM 2 Case JK is a 45-year-old male who arrives for his three month follow up A1c check and visit. His past medical history is significant for type 2 diabetes mellitus, hypertension, dyslipidemia, and CKD. His current medications include atorvastatin 40mg QD, HCTZ 25mg QAM, lisinopril 10mg QD, metformin 1,000mg BID and sitagliptin 100mg QD. Labs: Glucose 180mg/dL A1C 7.8% Urine albumin 716mg/g Sodium 136mEq/L Blood pressure: 132/78 Based on the above information, what is the most appropriate change to make to this patient’s regimen at this time? Add dapagliflozin Add liraglutide Add glipizide Continue current regimen with no changes None 5. PrEP A patient comes to you asking about “PrEP” medications for HIV. What agents are preferentially used for this therapy? Zidovudine and lopinavir/ritonavir Raltegravir Tenofovir DF and emtricitabine Enfuvirtide and maraviroc None 6. Insomnia Medications - Drug Interactions JS is a 54-year-old male who has recently been diagnosed with insomnia. His PCP has tried non-drug interventions with no success and they would like to try a medication. JS has gastroparesis and is taking erythromycin routinely. Which insomnia medication would avoid CYP3A4 drug interactions? Alprazolam Zolpidem Eszopiclone Doxepin None 7. Mortality and CHF One of the medical residents that you work with has a patient on numerous medications for CHF. The patient has a history of reduced ejection fraction heart failure. The resident would like to try to reduce the patient’s medications as the patient is requesting this. She would like to know which medication is least likely to improve mortality? Sacubitril/valsartan Spironolactone Carvedilol Digoxin None 8. Data Interpretation - Dapagliflozin Two groups are set up. One group will receive canagliflozin and the other will receive dapagliflozin. The incidence of pancreatitis has been followed for one year. For the canagliflozin group, the odds ratio with a 95% confidence interval is represented as 1.36-2.38. The dapagliflozin 95% CI odds ratio was reported as 0.76-1.77. What does this data tell us? Dapagliflozin and canagliflozin both are associated with increasing the risk of pancreatitis Canagliflozin is associated with a higher risk of pancreatitis, but dapagliflozin is not Neither are associated with increasing the risk of pancreatitis Dapagliflozin potentially reduces the risk of pancreatitis None 9. Niacin Risks Which of the following disease states would be concerning in a patient starting niacin? Crohn’s disease Gout Pulmonary hypertension Raynaud’s disorder None 10. Impetigo One of your pediatric patients has been diagnosed with impetigo. Which of the following agents would be most effective as a first-line agent for a localized infection? Bacitracin Polymixin B Triamcinolone Mupirocin None Time's up Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
